Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1999
12/16/1999WO1999064060A1 Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein
12/16/1999WO1999064059A2 Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders
12/16/1999WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999WO1999064054A1 Multibinding inhibitors of topoisomerase
12/16/1999WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064052A1 Novel leukotriene receptor antagonists and their uses
12/16/1999WO1999064051A1 Novel antibacterial compounds
12/16/1999WO1999064050A1 Novel potassium channel drugs and their uses
12/16/1999WO1999064049A1 Novel antibacterial agents
12/16/1999WO1999064048A1 Inhibitors of hiv reverse transcriptase
12/16/1999WO1999064047A1 Novel antiviral compounds
12/16/1999WO1999064045A1 Novel therapeutic agents for membrane transporters
12/16/1999WO1999064043A1 Muscarinic receptor antagonists
12/16/1999WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999WO1999064039A1 Bradykinin antagonists
12/16/1999WO1999064038A1 Novel analgesic agents
12/16/1999WO1999064037A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064033A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064028A1 Protecting neurons from ischemia
12/16/1999WO1999064022A1 Prophylactic and therapeutic nutritional supplement for creation/maintenance of health-protective intestinal microflora and enhancement of the immune system
12/16/1999WO1999064021A1 hCEPR RECEPTOR
12/16/1999WO1999064016A1 Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c
12/16/1999WO1999064013A1 Pharmaceutical composition with tumor necrosis factor a and 2-methoxyestrone-3-o-sulphamate for inhibition of estrone sulphatase
12/16/1999WO1999064011A1 Drugs
12/16/1999WO1999064010A1 Use of a nk-1 receptor antagonist for treating psychiatric disorders
12/16/1999WO1999064007A1 Use of a nk-1 receptor antagonist for treating bipolar disorders
12/16/1999WO1999064006A1 Use of a nk-1 receptor antagonist for treating psychiatric disorders
12/16/1999WO1999064004A1 QUINAZOLINONE INHIBITORS OF cGMP PHOSPHODIESTERASE
12/16/1999WO1999064002A1 Spiropiperidine derivatives as melanocortin receptor agonists
12/16/1999WO1999064001A2 Methods and compositions for increasing penetration of hiv protease inhibitors
12/16/1999WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999WO1999063999A1 H1-histamine receptor antagonists
12/16/1999WO1999063998A1 Novel use of hiv protease inhibiting compounds
12/16/1999WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999WO1999063992A1 Novel calcium channel drugs and uses
12/16/1999WO1999063988A1 Inhibitors of nitric oxide synthase
12/16/1999WO1999063987A1 N-acetyl 3-chloroprocainamide, acid addition salts thereof, and methods of use
12/16/1999WO1999063984A1 Novel sodium channel drugs and uses
12/16/1999WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
12/16/1999WO1999063981A2 Use of alkylating compounds for inhibiting proliferation of arterial smooth muscle cells
12/16/1999WO1999063980A1 Treatment of anti-estrogen resistant breast cancer using rxr modulators
12/16/1999WO1999063976A2 Liver-selective glucocorticoid antagonist for treating diabetes
12/16/1999WO1999063973A2 PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL
12/16/1999WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999WO1999063940A2 INHIBITORS OF H+K+-ATPase
12/16/1999WO1999063939A2 Multibinding inhibitors of cyclooxygenase-2
12/16/1999WO1999063937A2 Multivalent macrolide antibiotics
12/16/1999WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999WO1999063932A2 Multibinding agents that modulate the 5-ht transporter
12/16/1999WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999WO1999063929A2 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999WO1999063900A1 Improved methods and apparatus for multi-photon photo-activation of therapeutic agents
12/16/1999WO1999063828A1 Broad specificity dna damage endonuclease
12/16/1999WO1999057251A3 Thrombolytic agents derived from streptokinase
12/16/1999WO1999050268A3 Substituted indolealkanoic acids
12/16/1999WO1999049015A3 Cardiac-derived stem cells
12/16/1999WO1999043807A3 Human channel-related molecules
12/16/1999WO1999043651A3 Inhibitors of phospholipase enzymes
12/16/1999WO1999041373A3 Human transport-associated molecules
12/16/1999WO1999006540A3 Inhibitors of cell-cycle progression and uses related thereto
12/16/1999CA2335339A1 .beta.-carboline compounds
12/16/1999CA2334990A1 Novel use of hiv protease inhibiting compounds
12/16/1999CA2334979A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
12/16/1999CA2334970A1 Quinazolinone inhibitors of cgmp phosphodiesterase
12/16/1999CA2334945A1 Imidazolyl derivatives
12/16/1999CA2334872A1 Use of exendin-4 to treat impaired glucose tolerance
12/16/1999CA2334814A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
12/16/1999CA2334798A1 1,5-benzodiazepine derivatives
12/16/1999CA2334788A1 N-acetyl 3-chloroprocainamide, acid addition salts thereof, and methods of use
12/16/1999CA2334696A1 Purification process for production of mannan-binding lectin and an mbl medicinal product
12/16/1999CA2334671A1 Pyrido¬2,3-b|indolizine derivatives and aza analogues thereof; crf1 specific ligands
12/16/1999CA2334652A1 Protease inhibitors
12/16/1999CA2334611A1 Use of a nk-1 receptor antagonist for treating psychiatric disorders
12/16/1999CA2334609A1 Use of a nk-1 receptor antagonist for treating psychiatric disorders
12/16/1999CA2334580A1 Use of a nk-1 receptor antagonist for treating bipolar disorders
12/16/1999CA2334551A1 Spiropiperidine derivatives as melanocortin receptor agonists
12/16/1999CA2334545A1 Treatment of anti-estrogen resistant breast cancer using rxr modulators
12/16/1999CA2334116A1 Treatment of diabetes
12/16/1999CA2333890A1 Inhibition of coagulation in blood and blood products
12/16/1999CA2333691A1 Heterobicyclic and tricyclic nitric oxide synthase inhibitors
12/16/1999CA2333657A1 Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders
12/16/1999CA2333629A1 Furopyridine derivatives and their therapeutical use
12/16/1999CA2333551A1 A process for the preparation of macrocyclic metalloprotease inhibitors
12/16/1999CA2333175A1 Improved methods and apparatus for multi-photon photo-activation of therapeutic agents
12/16/1999CA2332993A1 Phagocytic assay method
12/16/1999CA2332314A1 Use of alkylating compounds for inhibiting proliferation of arterial smooth muscle cells
12/16/1999CA2331918A1 Protecting neurons from ischemia
12/16/1999CA2331794A1 Acetylcholine enhancers
12/16/1999CA2331372A1 Tankyrase, a trfi binding protein
12/16/1999CA2330247A1 Peptide inhibitors of hepatitis c virus ns3 protease
12/16/1999CA2330229A1 Novel angiotensin receptor, production and use thereof
12/16/1999CA2329688A1 Cell cycle regulation proteins
12/16/1999CA2329685A1 Proteins regulating gene expression
12/16/1999CA2321274A1 Novel antiviral compounds
1 ... 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 ... 1564